drugset / Trial / NCT00357539

Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers

NCT00357539

Phase 1 Completed Laboratoires Thea
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the ocular tolerance, safety and ocular pharmacokinetics of 3 concentrations (0.5% - 1.0% - 1.5%) and the vehicle of T1225.

Timeline

Start
2002-02
Primary completion
Completion
2002-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 0.5 % Topical
Subject Azithromycin Small molecule 1 % Topical
Subject Azithromycin Small molecule 1.5 % Topical